Samanth Subramanian on India’s Vaccine Conundrum

Grand Tamasha

One of the enduring puzzles about the tragic second wave of COVID is how India, the world’s largest vaccine producer, faces an alarming shortage of vaccines.

A new essay by the journalist Samanth Subramanian for the online news organization Quartz argues that there’s no single answer, but rather a “timeline of dysfunction” marked by what he calls “government negligence, corporate profiteering, opaque contracting, and the inequities of the global pharmaceutical market."

Samanth is a senior reporter at Quartz covering the future of capitalism. He has previously written for the Guardian Long Read, the New Yorker, the New York Times Magazine, and WIRED. He's also the author of three books, including A Dominant Character: The Radical Science and Restless Politics of JBS Haldane, one of the New York Times' 100 Notable Books of 2020.

Samanth is Milan’s guest on the show this week and the two discuss how the Indian government has managed the deadly second wave of the COVID pandemic, the role the Serum Institute of India and its enigmatic CEO have played in India’s vaccine production, and the patchy rollout of the government’s vaccine delivery. Plus, the two discuss what the United States and the international community must do to help vaccinate the developing world.

Episode notes:

1. Samanth Subramanian, “In the push for new vaccines, taxpayers keep paying and paying,” Quartz.
2. Samanth Subramanian, “The US’ support for vaccine patent waivers still leaves plenty to be resolved,” Quartz.
3. Samanth Subramanian, “Why is India, the world’s largest vaccine producer, running short of vaccines?” Quartz.
4. Samanth Subramanian, “India is feeling all the pain—and none of the gain—of an undeclared lockdown,” Quartz.